SLC27A1: Solute Carrier Family 27 Member 1
Fatty Acid Transport Protein 1 (FATP1) – Key Regulator of Long-Chain Fatty Acid Uptake and Metabolism
Gene Information Card
| Symbol | SLC27A1 |
|---|---|
| Full Name | Solute Carrier Family 27 Member 1 |
| Gene Type | Protein-coding |
| Chromosomal Location | 19p13.11 |
| NCBI Gene ID | 376497 ncbi.nlm.nih.gov/gene/376497 |
| Ensembl ID | ENSG00000130304 |
| UniProt ID | Q6PCB7 |
| OMIM ID | 604194 |
| HGNC ID | 10995 |
| Aliases | FATP1, FATP, ACSVL5, VLACS, MGC71751 |
Description
SLC27A1 (Solute Carrier Family 27 Member 1) encodes fatty acid transport protein 1 (FATP1), a transmembrane protein that facilitates the uptake of long-chain and very long-chain fatty acids into cells. FATP1 also exhibits acyl-CoA synthetase activity, converting fatty acids to acyl-CoAs for lipid metabolism. It is highly expressed in tissues with active fatty acid utilization, such as adipose tissue, skeletal muscle, heart, and liver. SLC27A1 plays a critical role in lipid homeostasis, insulin sensitivity, and energy balance. Dysregulation is associated with metabolic disorders, including obesity, insulin resistance, and type 2 diabetes.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Obesity and Insulin Resistance | Altered FATP1 expression affects fatty acid uptake in adipose and muscle, contributing to lipid accumulation and impaired insulin signaling. | PMID: 15677334, PMID: 17989211 |
| Type 2 Diabetes | Increased SLC27A1 expression in skeletal muscle correlates with insulin resistance and altered lipid metabolism. | PMID: 11549629, PMID: 17989211 |
| Metabolic Syndrome | Variants in SLC27A1 are associated with dyslipidemia and increased risk of metabolic syndrome. | PMID: 17989211 |
| Lipodystrophy | Defective fatty acid transport due to SLC27A1 mutations may contribute to lipodystrophic phenotypes. | OMIM: 604194 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Adipose tissue | 12.5 | High |
| Skeletal muscle | 8.3 | Medium |
| Heart | 7.1 | Medium |
| Liver | 5.2 | Low |
| Kidney | 4.8 | Low |
| Brain | 2.1 | Not detected |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HepG2 | 6.0 | Hepatocyte cell line |
| C2C12 | 9.5 | Mouse myoblast cell line |
| 3T3-L1 | 14.2 | Adipocyte cell line |
| HeLa | 3.1 | Cervical cancer cell line |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.763C>T (p.Arg255Trp) | Missense | 0.0002 (gnomAD) | Reduced fatty acid uptake activity |
| c.1124G>A (p.Arg375Gln) | Missense | 0.0001 (gnomAD) | Altered acyl-CoA synthetase activity |
| c.1445T>C (p.Leu482Pro) | Missense | 0.00005 (gnomAD) | Impaired protein stability |
| c.1726G>A (p.Gly576Ser) | Missense | 0.0001 (gnomAD) | Unknown functional effect |
Mutation functional classification
Loss of Function (LOF)
Missense variants (e.g., p.Arg255Trp) reduce fatty acid transport and acyl-CoA synthetase activity, leading to decreased cellular fatty acid uptake.
Gain of Function (GOF)
No confirmed gain-of-function mutations reported in SLC27A1.
Dominant Negative (DN)
No evidence of dominant-negative effects for SLC27A1 mutations.
View complete mutation data:
Gene Ontology (GO)
| • long-chain fatty acid transporter activity (GO:0005326) | • long-chain fatty acid-CoA ligase activity (GO:0004467) |
| • fatty acid transport (GO:0015908) | • fatty acid metabolic process (GO:0006631) |
| • integral component of membrane (GO:0016021) | • mitochondrion (GO:0005739) |
Pathways
• Fatty acid transport (Reactome: R-HSA-382551)
• Fatty acid metabolism (KEGG: hsa00071)
• PPAR signaling pathway (KEGG: hsa03320)
• Adipocytokine signaling pathway (KEGG: hsa04920)
Protein Summary
The SLC27A1 protein (FATP1) is a 646-amino acid transmembrane protein with a molecular weight of approximately 71 kDa. It contains a mitochondrial targeting sequence and a conserved AMP-binding domain characteristic of acyl-CoA synthetases. FATP1 localizes to the plasma membrane and mitochondria, where it mediates both the transport of long-chain fatty acids and their conversion to acyl-CoAs. The protein is regulated by insulin and PPARγ agonists, and its expression is induced during adipocyte differentiation. Structural studies indicate that FATP1 forms homodimers and interacts with other lipid metabolism proteins. Post-translational modifications include phosphorylation at Ser-247, which modulates activity.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SLC27A1 Knockout HEK293 Cell Line | EDJ-KQ3543 | Human | 376497 | Details Get a Quote |
| SLC27A1 Knockout A-549 Cell Line | EDJ-KQ25390 | Human | 376497 | Details Get a Quote |
| SLC27A1 Knockout HCT 116 Cell Line | EDJ-KQ25391 | Human | 376497 | Details Get a Quote |
| SLC27A1 Knockout HeLa Cell Line | EDJ-KQ25392 | Human | 376497 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records